In a series of enlightening discussions, Kenny and Chip delve into the evolving landscape of the cannabis industry, exploring topics ranging from international expansion to the implications of Schedule Three classification. These two industry insiders provide valuable insights into the opportunities and challenges facing the cannabis sector and shed light on the transformative potential of pharmaceutical involvement.
Key Insights from the Interview:
1. Expanding Horizons: The International Cannabis Market
Kenny shares his experiences navigating the international cannabis market, highlighting the growing interest in medical cannabis education and research outside the United States. He discusses the need to meet doctors where they are and emphasizes the importance of providing peer-reviewed content on the endocannabinoid system to healthcare professionals globally.
2. The Intersection of Cannabis and Pharmaceuticals
Chip and Kenny explore the implications of pharmaceutical involvement in the cannabis industry. They discuss the potential benefits of Schedule Three classification, including increased market capitalization, credibility, and research opportunities. While acknowledging concerns about pharma's role, they emphasize the positive impact it could have on patient access, affordability, and innovation.
3. Breaking Barriers: Education and Awareness
Education emerges as a central theme in their conversations, with both Kenny and Chip stressing the importance of providing accurate, evidence-based information on cannabis and the endocannabinoid system. They underscore the need to bridge the gap between medical professionals and cannabis education, particularly in regions where there is a hunger for knowledge on medical cannabis.
4. Embracing Collaboration for Progress
Throughout their discussions, Kenny and Chip advocate for collaboration and innovation as driving forces behind positive change in the cannabis industry. They highlight the potential for partnerships between commercial operators and pharmaceutical companies to spur research, development, and access to medical cannabis treatments.
5. Looking Ahead: Opportunities and Challenges
As they reflect on the future of the cannabis industry, Kenny and Chip express optimism about the opportunities for growth and advancement. They acknowledge the challenges ahead, including regulatory hurdles and lingering stigma, but remain hopeful that continued collaboration and advocacy will pave the way for progress.
In conclusion, Kenny and Chip's conversations offer valuable insights into the dynamic landscape of the cannabis industry and the transformative potential of pharmaceutical involvement. By embracing collaboration, innovation, and education, stakeholders can work together to unlock the full potential of medical cannabis and improve outcomes for patients worldwide.
Contact Information:
Chip Paul
Email: chip@neighborlywellness.com
Websites: truemedx.com, neighborlywellness.com
LinkedIn: https://www.linkedin.com/in/chiptalks/
Podcast: https://youtube.com/@ChipTalks?si=LFyzT3PfQ79G4rNu
Ken Watkins
LinkedIn Profile: linkedin.com/in/ken-watkins-b2791310
Company Website: watkinsrepgroup.com/home.html
Phone: 862 686 0986
Email: ken@ajendomed.com
Trusted Partners:
Neighborly Nutrition Thermal Imaging & Bioresonance Clinic
TrueMedX Nutrition
In a series of enlightening discussions, Kenny and Chip delve into the evolving landscape of the cannabis industry, exploring topics ranging from international expansion to the implications of Schedule Three classification. These two industry insiders provide valuable insights into the opportunities and challenges facing the cannabis sector and shed light on the transformative potential of pharmaceutical involvement.
Key Insights from the Interview:
1. Expanding Horizons: The International Cannabis Market
Kenny shares his experiences navigating the international cannabis market, highlighting the growing interest in medical cannabis education and research outside the United States. He discusses the need to meet doctors where they are and emphasizes the importance of providing peer-reviewed content on the endocannabinoid system to healthcare professionals globally.
2. The Intersection of Cannabis and Pharmaceuticals
Chip and Kenny explore the implications of pharmaceutical involvement in the cannabis industry. They discuss the potential benefits of Schedule Three classification, including increased market capitalization, credibility, and research opportunities. While acknowledging concerns about pharma's role, they emphasize the positive impact it could have on patient access, affordability, and innovation.
3. Breaking Barriers: Education and Awareness
Education emerges as a central theme in their conversations, with both Kenny and Chip stressing the importance of providing accurate, evidence-based information on cannabis and the endocannabinoid system. They underscore the need to bridge the gap between medical professionals and cannabis education, particularly in regions where there is a hunger for knowledge on medical cannabis.
4. Embracing Collaboration for Progress
Throughout their discussions, Kenny and Chip advocate for collaboration and innovation as driving forces behind positive change in the cannabis industry. They highlight the potential for partnerships between commercial operators and pharmaceutical companies to spur research, development, and access to medical cannabis treatments.
5. Looking Ahead: Opportunities and Challenges
As they reflect on the future of the cannabis industry, Kenny and Chip express optimism about the opportunities for growth and advancement. They acknowledge the challenges ahead, including regulatory hurdles and lingering stigma, but remain hopeful that continued collaboration and advocacy will pave the way for progress.
In conclusion, Kenny and Chip's conversations offer valuable insights into the dynamic landscape of the cannabis industry and the transformative potential of pharmaceutical involvement. By embracing collaboration, innovation, and education, stakeholders can work together to unlock the full potential of medical cannabis and improve outcomes for patients worldwide.
Contact Information:
Chip Paul
Email: chip@neighborlywellness.com
Websites: truemedx.com, neighborlywellness.com
LinkedIn: https://www.linkedin.com/in/chiptalks/
Podcast: https://youtube.com/@ChipTalks?si=LFyzT3PfQ79G4rNu
Ken Watkins
LinkedIn Profile: linkedin.com/in/ken-watkins-b2791310
Company Website: watkinsrepgroup.com/home.html
Phone: 862 686 0986
Email: ken@ajendomed.com
Trusted Partners:
Neighborly Nutrition Thermal Imaging & Bioresonance Clinic
TrueMedX Nutrition